Treves Nir, Yakirevich-Amir Noa, Abu Ahmad Wiessam, Bonne Omer, Davidson Elyad, Keeling Keenan, Hall Branden, Dautrich Tyler, Matok Ilan
Division of Clinical Pharmacy, School of Pharmacy, The Hebrew University, Jerusalem, Israel.
Department of Psychiatry, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):407-420. doi: 10.1007/s00406-024-01812-0. Epub 2024 Jun 11.
There is a potential link between cannabis and mental disorders. Cannabis exposure involves in many cases negative mental emotions, which are unpleasant sensations or thoughts. Whereas mild cases of negative mental emotions inflict patient's quality of life, more severe cases lead to therapy discontinuations, or even hospitalizations and death. This study characterizes cannabis users who experienced negative mental emotions after cannabis exposure. The Releaf App database was utilized to evaluate the association between personal and cannabis use characteristics on reporting a negative mental emotion during cannabis exposure. This global mobile lets individuals track real-time cannabis experience use with cannabinoid-based products, containing data points such as gender, age, reasons for use, product type, cannabis composition, and feelings and emotions experienced after cannabis use. Multivariable logistic regression models were constructed, adjusting for potential confounders such as gender and previous experience with cannabis use. The study population comprised 4,435 users, and 34,279 sessions were collected from various countries, mainly from North America, and included in the primary analysis. Reporting on negative mental emotions was associated with users in the age group of 18-30 years. Using cannabis for a mental purpose was associated with a small increase in reporting on negative mental emotions (OR = 1.10, 95%CI [1.03-1.19]). Oral products were associated with reporting on negative mental emotions. THC-dominant products were associated with reporting negative mental emotions compared to balanced products (OR = 1.21, 95%CI [1.06-1.38]). This study suggests that some characteristics of cannabis use, such as young age and oral consumption are associated with negative mental emotions. Further studies should examine the interface between cannabis consumption, characteristics of consumers, and negative emotional experience or even long-term mental disorders.
大麻与精神障碍之间可能存在联系。在许多情况下,接触大麻会引发负面情绪,这些都是不愉快的感觉或想法。轻度的负面情绪会影响患者的生活质量,而更严重的情况则会导致治疗中断,甚至住院和死亡。本研究对接触大麻后出现负面情绪的大麻使用者进行了特征描述。利用Releaf应用程序数据库评估个人特征和大麻使用特征与报告接触大麻期间负面情绪之间的关联。这个全球移动应用程序让个人能够追踪使用基于大麻素产品的实时大麻体验,包含的数据点有性别、年龄、使用原因、产品类型、大麻成分以及使用大麻后的感受和情绪。构建了多变量逻辑回归模型,对性别和大麻使用既往经历等潜在混杂因素进行了调整。研究人群包括4435名使用者,从不同国家收集了34279次使用记录,主要来自北美,并纳入了初步分析。报告负面情绪与18 - 30岁年龄组的使用者有关。出于精神目的使用大麻与报告负面情绪的小幅增加有关(比值比=1.10,95%置信区间[1.03 - 1.19])。口服产品与报告负面情绪有关。与均衡产品相比,以四氢大麻酚为主的产品与报告负面情绪有关(比值比=1.21,95%置信区间[1.06 - 1.38])。本研究表明,大麻使用的一些特征,如年轻和口服消费,与负面情绪有关。进一步的研究应考察大麻消费、消费者特征与负面情绪体验甚至长期精神障碍之间的关系。